Neuroblastoma incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System Project

被引:142
作者
Spix, Claudia [1 ]
Pastore, Guido
Sankila, Risto
Stiller, Charles A.
Steliarova-Foucher, Eva
机构
[1] Johannes Gutenberg Univ Mainz, German Childhood Canc Registry, D-55101 Mainz, Germany
[2] Univ Piemonte Orientale, Div Pediat, Dept Med Sci, Novara, Italy
[3] Univ Turin, Childhood Canc Registry Piedmont, Canc Epidemiol Unit, Ctr Canc Epidemiol & Prevent,CPO Piemonte,CeRMS, I-10124 Turin, Italy
[4] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland
[5] Univ Oxford, Childhood Canc Res Grp, Dept Paediat, Oxford, England
[6] Int Agcy Res Canc, Descript Epidemiol Grp, F-69372 Lyon, France
关键词
childhood cancer; neuroblastoma; registry; Europe; survival; incidence; trend;
D O I
10.1016/j.ejca.2006.05.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Automated Childhood Cancer Information System (ACCIS) collects and presents data on childhood cancer in Europe. This report describes trends (1978-1997) and geographical differences (1988-1997) in incidence and survival for 6202 children with neuroblastoma from 59 registries in 19 countries, grouped into five regions (British Isles, West, East, North, and South). The age-standardised incidence rate (ASR) of neuroblastoma in Europe in 19881997 was 10.9 cases per million children, being highest in infants (52.6). The ASR of neuroblastoma increased in Europe from 8.4 in 1978-1982 to 11.6 in 1993-1997, mostly due to an increase in infants (from 35.4 to 57.8). Overall 5-year survival vias 59%, ranging from 47% (East) to 67% (West). It improved markedly from 37% in 1978-1982 to 66% in 1993-1997, especially in infants. A certain amount of overdiagnosis in children under 2 years of age may explain the increased incidence rates and partially the increase in survival. Survival of older children (aged 2-14 years), which is likely to be largely affected by therapy, has also improved from 21% to 45%. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2081 / 2091
页数:11
相关论文
共 34 条
  • [1] Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age
    Berthold, F
    Hero, B
    Kremens, B
    Handgretinger, R
    Henze, G
    Schilling, FH
    Schrappe, M
    Simon, T
    Spix, C
    [J]. CANCER LETTERS, 2003, 197 (1-2) : 11 - 17
  • [2] Neuroblastoma: Biological insights into a clinical enigma
    Brodeur, GM
    [J]. NATURE REVIEWS CANCER, 2003, 3 (03) : 203 - 216
  • [3] BRODEUR GM, 2000, NEUROBLASTOMA
  • [4] Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany
    Burkhardt-Hammer, T
    Spix, C
    Brenner, H
    Kaatsch, P
    Berthold, F
    Hero, B
    Michaelis, J
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 39 (03): : 156 - 162
  • [5] A comparison of current neuroblastoma chemotherapeutics
    Castel, V
    Cañete, A
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (01) : 71 - 80
  • [6] Outcome of high-risk neuroblastoma using a dose intensity approach:: Improvement in initial but not in long-term results
    Castel, V
    Cañete, A
    Navarro, S
    García-Miguel, P
    Melero, C
    Acha, T
    Navajas, A
    Badal, MD
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (06): : 537 - 542
  • [7] Chauvin F, 1997, MED PEDIATR ONCOL, V28, P81, DOI 10.1002/(SICI)1096-911X(199702)28:2<81::AID-MPO1>3.0.CO
  • [8] 2-O
  • [9] Maternal medication use and neuroblastoma in offspring
    Cook, MN
    Olshan, AF
    Guess, HA
    Savitz, DA
    Poole, C
    Blatt, J
    Bondy, ML
    Pollock, BH
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (08) : 721 - 731
  • [10] Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992
    Cotterill, SJ
    Pearson, ADJ
    Pritchard, J
    Foot, ABM
    Roald, B
    Kohler, JA
    Imeson, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (07) : 901 - 908